Development of castration resistance in prostate cancer patients treated with luteinizing hormone-releasing hormone analogues (LHRHa): results of the ANARESISTANCE study.

Published in:

World Journal of Urology, 2022, v. 40, n. 10, p. 2459, doi. 10.1007/s00345-022-04108-x

By:

• Angulo, J. C.;
• Ciria Santos, J. P.;
• Gómez-Caamaño, A.;
• Poza de Celis, R.;
• González Sala, J. L.;
• García Garzón, J. M.;
• Galán-Llopis, J. A.;
• Pérez Sampietro, M.;
• Perrot, V.;
• Planas Morin, J.;
• on behalf of ANARESISTANCE study group;
• Abascal, José Manuel;
• Barrond, Víctor;
• Benedicto, Antonio;
• Carballo, Ana;
• Cortiñas, José Ramón;
• Fernández, Manuel;
• Ferrer, Eduardo;
• Guzmán, Pablo Luís;
• López, Miguel Ángel

Publication type:

Article